计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| M650002-5mg |
5mg |
期货 ![]() |
| |
| M650002-10mg |
10mg |
期货 ![]() |
| |
| M650002-25mg |
25mg |
期货 ![]() |
| |
| M650002-50mg |
50mg |
期货 ![]() |
| |
| M650002-100mg |
100mg |
期货 ![]() |
|
| 规格或纯度 | Moligand™, ≥98% |
|---|---|
| 英文名称 | MS049 |
| 生化机理 | MS049 是 PRMT4 和 PRMT6 的强效、选择性和细胞活性双重抑制剂,其 IC 50 s 分别为 34 nM 和 43 nM。MS049 可降低 HEK293 细胞中 Med12me2a 和 H3R2me2a 的水平。MS049 没有毒性,也不影响 HEK293 细胞的生长。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
MS049 is a potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with IC 50 s of 34 nM and 43 nM, respectively. MS049 reduces levels of Med12me2a and H3R2me2a in HEK293 cells. MS049 is not toxic and does not affect the growth of HEK293 cells In Vitro MS049 (0.1-10 μM; 20 hours) reduces the H3R2me2a mark in HEK293 cells in a concentration dependent manner (IC 50 =0.97±0.05 μM). MS049 (0.1-100 μM; 72 hours) inhibits endogenous PRMT4 methyltransferase activity in a concentration dependent manner resulting in reduced levels of cellular asymmetric arginine dimethylation of Med12 (Med12-Rme2a, IC 50 =1.4±0.1 μM) in HEK293 cells. MS049 is selective for PRMT4 and PRMT6 over a broad range of epigenetic modifiers, including other PRMTs, PKMTs, DNMTs, KDMs, and methyllysine/methylarginine reader proteins, and non-epigenetic targets. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: HEK293 cells Concentration: 0.1, 1, 10 μM Incubation Time: 20 hours Result: Reduced the H3R2me2a mark in HEK293 cells in a concentration dependent manner (IC 50 =0.97±0.05 μM). Western Blot AnalysisCell Line: HEK293 cells Concentration: 0.1, 1, 10, 100 μM Incubation Time: 72 hours Result: Reduced levels of cellular asymmetric arginine dimethylation of Med12 (Med12-Rme2a, IC 50 =1.4±0.1 μM) in HEK293 cells. Form:Solid IC50& Target:PRMT4 34 nM () PRMT6 43 nM () PRMT8 1600 nM () |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | N-methyl-2-(4-phenylmethoxypiperidin-1-yl)ethanamine |
| INCHI | 1S/C15H24N2O/c1-16-9-12-17-10-7-15(8-11-17)18-13-14-5-3-2-4-6-14/h2-6,15-16H,7-13H2,1H3 |
| InChi Key | HBOJWAYLSJLULG-UHFFFAOYSA-N |
| Smiles | CNCCN1CCC(CC1)OCC2=CC=CC=C2 |
| Isomeric SMILES | CNCCN1CCC(CC1)OCC2=CC=CC=C2 |
| 分子量 | 248.36 |
| Reaxy-Rn | 30181165 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=30181165&ln= |
| 溶解性 | H2O : ≥ 100 mg/mL (402.64 mM) DMSO : ≥ 31 mg/mL (124.82 mM) |
|---|---|
| 分子量 | 248.360 g/mol |
| XLogP3 | 1.700 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 3 |
| 可旋转键计数Rotatable Bond Count | 6 |
| 精确质量Exact Mass | 248.189 Da |
| 单同位素质量Monoisotopic Mass | 248.189 Da |
| 拓扑极表面积Topological Polar Surface Area | 24.500 Ų |
| 重原子数Heavy Atom Count | 18 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 209.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |